Systemic proteome alterations linked to early stage pancreatic cancer in diabetic patients

Keyphrases

• Adult-onset Diabetes 20%
• Apolipoprotein A-IV 20%
• Area under the Curve 20%
• Biomarker Candidates 20%
• Biomarker Panel 80%
• Blood Biomarkers 20%
• C1 Inhibitor 20%
• Cancer Detection 20%
• Carbohydrate Antigen 19-9 (CA19-9) 40%
• CD14 40%
• CLEC3B 20%
• Detection Accuracy 40%
• Diabetes 20%
• Diabetic 40%
• Diabetic Patients 100%
• Differentiation Antigen 20%
• Early Diagnosis 20%
• Early Pancreatic Cancer 100%
• Early Signs 20%
• Fold Increase 20%
• Gelsolin 20%
• Heavy Chain 20%
• High-risk Population 20%
• Histidine-rich Glycoprotein 20%
• Imaging Tests 20%
• Inhibitor-1 20%
• Inter-α-trypsin Inhibitor 20%
• KLKB1 20%
• Leucine-rich alpha-2 Glycoprotein 20%
• LRG1 20%
• Model Building 20%
• Monocyte Differentiation 20%
• Multiple Biomarkers 20%
• Omics Platforms 20%
• Pancreatic Ductal Adenocarcinoma 100%
• Pancreatic Malignancy 20%
• Pigment Epithelium-derived Factor 20%
• Plasma Kallikrein 20%
• Plasma Samples 20%
• Potential Biomarkers 20%
• Prediction Model 20%
• Prediction Probability 20%
• Protease 20%
• Proteome 100%
• Proteomics 20%
• Random Forest Algorithm 20%
• Realistic Approach 20%
• Receiver Operating Characteristic Analysis 20%
• Risk Factors 20%
• SERPINF1 20%
• SERPING1 20%
• Spectral Library 20%
• Tetranectin 20%
• Tissue Inhibitor of metalloproteinase-1 (TIMP-1) 40%
• Well-defined 20%

Biochemistry, Genetics and Molecular Biology

• Apolipoprotein 50%
• Blood Plasma 100%
• C1-Inhibitor 50%
• CD14 100%
• Gelsolin 50%
• Glycoprotein 100%
• Heavy Chain 50%
• Histidine 50%
• Inter-Alpha-Trypsin Inhibitor 50%
• KLKB1 50%
• Leucine 50%
• Metalloprotease Inhibitor 50%
• Photosynthetic Pigment 50%
• Plasma Kallikrein 50%
• Population Risk 50%
• Protease 50%
• Proteome 100%
• Proteomics 100%
• Random Forest 50%
• TIMP1 50%